Bluesail Surgical participated in IFSO again with RenoVue®/RenoPort® Novel Intra-Abdominal Lens Cleaning Device, showing the strength of independent research & development and innovation!

Add Time2023.12.02

On 30 November-2 December 2023, the 8th International Federation of Obesity Metabolic Surgery Asia-Pacific (IFSO-APC) Meeting and the 10th Chinese Society of Obesity and Diabetes Surgery (CSMBS) Meeting were successfully held in Shenzhen, China. Nearly 1,000 experts in the fields of obesity metabolic surgery, basic and translational metabolic research, comprehensive health management, etc. from 35 countries gathered around the theme of "The Future of Obesity Metabolic Surgery in Asia-Pacific Region" to express their views and share their opinions on the frontiers of multidisciplinary development of obesity metabolism.

According to Prof. Wang Cunchuan, the current president of IFSO-APC, the director of CSMBS, and the leader of the Weight Loss Centre of the First Affiliated Hospital of Jinan University, the International Federation of Obesity and Metabolic Surgery (hereinafter referred to as IFSO) is the world's most influential international obesity and metabolic surgical academic organization. IFSO is consists of healthcare professionals engaged in the surgical treatment of obesity and metabolic diseases and healthcare professionals of related disciplines in 72 countries and regions. They are committed to establishing a global obesity treatment center and a certification system for surgical care. The IFSO Congress is known as the "Olympics" in the field of obesity metabolic surgery, and the IFSO-APC Annual Congress is also known as the "Asian Games" in this field.

Bluesail Surgical booth was crowded with visitors.

Bluesail Surgical took this opportunity to display not only the innovative RenoVue® / RenoPort® Novel Intra-Abdominal Lens Cleaning Device, but also a full range of new surgical products, including Astrolux® and Siderlux® series for Powered Endocutter, TisFree® ultrasonic soft tissue dissectiond and hemostasis system and other important products developed by Bluesail Surgical. These line up are important Novel products.

The most eye-catching is the Novel product of Bluesail Surgical - RenoVue®/ RenoPort® Novel Intra-Abdominal LensCleaning Device, which attracted the attention of experts, agents and other exhibitors at home and abroad when it was unveiled.

It also attracted the attention of WICB, the official media responsible for reporting the conference. WICB firstly invited Mr Zhang Lei, Marketing Director of Bluesail Surgical, to introduce the novel concept and working principle of RenoVue® / RenoPort®, and also demonstrated how the cleaning device can help doctors to achieve high efficiency of cleaning in-situ. At the end of the interview, the reporter of Microinvasive Broadcast also conducted an in-depth interview with Zhang Lei, Marketing Director of Bluesail Surgical. The interview provided an in-depth understanding of Bluesail Surgical's commitment to promoting global surgical therapies in the direction of more accurate, minimally invasive and non-invasive treatments with fewer complications and better prognosis, as well as its determination to benefit patients with all kinds of benign and malignant diseases around the world.

eeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee

In the background of minimally invasive surgery technology continues to progress, lens contamination is a common problem during the surgery. Compared with the traditional wiping and cleaning methods, Bluesail surgical’s RenoVue®/ Renoport®, by virtue of the world's first four core technologies namely: closed looped cleaning system, Pulsed Air-Ballistic Flow, the W-Base Anti-Fog coating technology, Contactless switches. These help the doctor achieve fast surgery, and able to ensure the safety of patients and at the same time greatly enhance the efficiency of the surgery.

Integration of the 4 core technologies provide clear vision during the surgery.

The shortest cleaning time is 2.4 seconds

Bluesail Surgical team has conducted thousands of gas-liquid mixing tests to confirm the optimal gas-liquid ratio to form a high-pressure Pulsed Air-Ballistic flow. Tens of thousands of tests was done to obtain stable and efficient cleaning performance, as well as thousands of tests to verify that the optimal flow channel and sealing film structure. After a number of iterative optimization of the technical version of the product, and eventually developed this product. According to the pre-launch clinical trial data, it takes only 2.4 seconds to complete the cleaning of laparoscopes with RenoVue®/ Renoport®, which reduces the lens cleaning time by 24 seconds on average compared with the traditional wiping method, effectively shortening the surgery time.

It is worth mentioning that the product’s Cannula, is universal for all types of lenses, and is suitable for all-laparoscopic surgeries of the stomach, intestines, liver, gallbladder and pancreas, esophagus, kidneys, bladder, uterus and adnexa, etc., Furthermore it can be used for laparoscopic exploration and surgical procedures. It is expected to be further popularized for use in other clinical applications in the future.

Bluesail Surgical has attracted a lot of attention during this exhibition, and we sincerely thank all the experts who came to visit our booth. The experts' recognition of Bluesail Surgical’s product quality and novel research and innovation inspired us to move forward. RenoVue®/RenoPort® is not only the world's first Intra-Abdominal Lens Cleaning Device but also the result of Bluesail Surgical's deep cultivation in the field of minimally invasive surgery. In the future, Bluesail Surgical will continue to make efforts to improve the product piepline of all-intelligent surgical solutions, so that high-quality and safe products will benefit more patients and make greater contributions to the development of surgical and medical undertakings.